Multidisciplinary, evidence-based consensus guidelines for human papillomavirus (HPV) vaccination in highrisk populations, Spain, 2016

Xavier Martínez-Gómez, Adrian Curran, Magda Campins, Laia Alemany, José Ángel Rodrigo-Pendás, Natalia Borruel, Xavier Castellsagué, Cristina Díaz-de-Heredia, Fernando A. Moraga-Llop, Marta del Pino, Aureli Torné

Research output: Contribution to journalArticleResearch

10 Citations (Scopus)

Abstract

© 2019, European Centre for Disease Prevention and Control (ECDC). All rights reserved. Introduction: Although human papillomavirus (HPV) routine vaccination programmes have been implemented around the world and recommendations have been expanded to include other high-risk individuals, current recommendations often differ between countries in Europe, as well as worldwide. Aim: To find and summarise the best available evidence of HPV vaccination in high-risk patients aiding clinicians and public health workers in the day-to-day vaccine decisions relating to HPV in Spain. Methods: We conducted a systematic review of the immunogenicity, safety and efficacy/effectiveness of HPV vaccination in high-risk populations between January 2006 and June 2016. HPV vaccination recommendations were established with levels of evidence according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system. Results: A strong recommendation about HPV vaccination was made in the following groups: HIV infected patients aged 9-26 years; men who have sex with men aged 9-26 years; women with precancerous cervical lesions; patients with congenital bone marrow failure syndrome; women who have received a solid organ transplant or hematopoietic stem cell transplantation aged 9-26 years; and patients diagnosed with recurrent respiratory papillomatosis. Conclusions: Data concerning non-routine HPV vaccination in populations with a high risk of HPV infection and associated lesions were scarce. We have developed a document to evaluate and establish evidence- based guidelines on HPV vaccination in highrisk populations in Spain, based on best available scientific evidence.
Original languageEnglish
Article number1700857
JournalEurosurveillance
Volume24
DOIs
Publication statusPublished - 14 Feb 2019

Fingerprint Dive into the research topics of 'Multidisciplinary, evidence-based consensus guidelines for human papillomavirus (HPV) vaccination in highrisk populations, Spain, 2016'. Together they form a unique fingerprint.

Cite this